Company: PIII
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001832511-25-000025
Chunk: 155

Company: P3 Health Partners Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 8
Chunk 155
---
,912 $830,588 $(256,238)$574,350 Amortization of intangible assets was $20.5 million and $21.0 million during the three months ended September 30, 2025 and 2024, respectively, and $61.4 million and $63.1 million during the nine months ended September 30, 2025 and 2024, respectively.

Note 8: DebtLong-term DebtLong-term debt consisted of the following:September 30, 2025December 31, 2024(in thousands)Repurchase promissory note, interest paid at 11.0%, due June 2026$33,242 $30,091 Term loan facility, interest paid at 12.0%, due September 202782,758 75,155 VGS 1 promissory note, interest paid at 13.5%, due June 202847,911 38,328 VGS 2 promissory note, interest paid at 17.5%, due September 202737,191 28,972 VGS 3 promissory note, interest paid at 19.5%, due June 202833,967 25,499 VGS 4 promissory note, interest paid at 19.5%, due August 202839,412 — VGS 5 promissory note, interest paid at 19.5%, due August 202837,768 — Long-term debt, gross312,249 198,045 Less: unamortized debt issuance costs and original issue discount(59,454)(13,983)252,795 184,062 Less: current portion of long-term debt(38,612)(75,155)Long-term debt, net$214,183 $108,907 VGS 4 Promissory NoteOn February 13, 2025, P3 LLC entered into a related party financing transaction with VBC Growth SPV 4, LLC (“VGS 4”), consisting of the issuance by P3 LLC of (i) an unsecured promissory note (the “VGS 4 Promissory Note”) to VGS 4 and (ii) a warrant to purchase 1.4 million shares of the Company’s Class A common stock at an exercise price of $10.34 per share to VGS 4, as adjusted for the reverse